Infect. Immun., Aug 1997, 3138-3145, Vol 65, No. 8
Copyright © 1997, American Society for Microbiology

Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens

JM Burns Jr, PD Dunn and DM Russo
Department of Microbiology, Meharry Medical College, Nashville, Tennessee 37208, USA.

The Plasmodium yoelii murine model was used to test several combinations of blood-stage antigens and adjuvants for the ability to induce immunity to blood-stage malaria. Upon fractionation of whole blood-stage antigen into soluble and insoluble components, only the particulate antigens (pAg) induced protective immune responses. Of a number of adjuvants tested, Quil A was the most effective. Immunization with pAg plus Quil A induced solid protection against nonlethal and lethal P. yoelii challenge infection. Analysis of cytokine production revealed mRNA for Th1-type cytokines (interleukin 2 [IL-2] and gamma interferon) as well as Th2-type cytokines (IL-4 and IL-10) in the spleens of both protected and susceptible animals. The data suggested that the protective pAg response was associated with the earlier production of cytokine mRNA with a Th2 phenotype somewhat favored. Immunization of B-cell-deficient JHD mice indicated that the protection against P. yoelii induced by pAg immunization was B cell dependent. Although immunization with pAg plus Quil A increased the levels of antigen-specific antibodies of all four immunoglobulin G (IgG) isotypes, protection correlated most closely with the presence of IgG1 and IgG2b antibodies. Sera from pAg-plus-Quil A-immunized animals recognized only a limited subset of six to eight distinct P. yoelii antigens, primarily associated with the pAg fraction. These results provide the basis for the identification and characterization of potential vaccine antigens, selected solely for their ability to immunize against blood-stage malaria.

This article has been cited by other articles:

• Siddiqui, A. A., Bora, H., Singh, N., Dash, A. P., Sharma, Y. D. (2008). Expression, Purification, and Characterization of the Immunological Response to a 40-Kilodalton Plasmodium vivax Tryptophan-Rich Antigen. Infect. Immun. 76: 2576-2586 [Abstract] [Full Text]  
• Shi, Q., Lynch, M. M., Romero, M., Burns, J. M. Jr. (2007). Enhanced Protection against Malaria by a Chimeric Merozoite Surface Protein Vaccine. Infect. Immun. 75: 1349-1358 [Abstract] [Full Text]  
• Dutta, S., Ware, L. A., Barbosa, A., Ockenhouse, C. F., Lanar, D. E. (2001). Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli. Infect. Immun. 69: 5464-5470 [Abstract] [Full Text]  
• Burns, J. M. Jr., Belk, C. C., Dunn, P. D. (2000). A Protective Glycosylphosphatidylinositol-Anchored Membrane Protein of Plasmodium yoelii Trophozoites and Merozoites Contains Two Epidermal Growth Factor-Like Domains. Infect. Immun. 68: 6189-6195 [Abstract] [Full Text]  
• Burns, J. M. Jr., Adeeku, E. K., Dunn, P. D. (1999). Protective Immunization with a Novel Membrane Protein of Plasmodium yoelii-Infected Erythrocytes. Infect. Immun. 67: 675-680 [Abstract] [Full Text]